Trials / Terminated
TerminatedNCT02211053
Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controled Trial
Evaluation of the Efficacy and Safety of Levothyroxine in Brain Death Organ Donors: a Randomized Controlled Trial
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal · Academic / Other
- Sex
- All
- Age
- 16 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the feasibility of a randomized controlled trial comparing levothyroxine to placebo in neurologically deceased donors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Levothyroxine | 20 mg IV bolus + 10 mg/h infusion |
| DRUG | placebo |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2014-08-07
- Last updated
- 2018-07-17
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT02211053. Inclusion in this directory is not an endorsement.